New research suggests that individuals who come off popular weight-loss injections like Wegovy and Mounjaro can put back on lost weight far faster than those who stop traditional lifestyle programs.
Findings released in a leading health publication points out that while overweight people often shed substantial amounts of their body weight while using the jabs, the mass is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"Users purchasing these drugs should be cognizant of the risk of fast rebound weight gain when the treatment ends," warns researcher Dr. Susan Jebb.
That rate of regain suggests a reversion to pre-treatment mass in about 18 months.
Analyzing Treatments
The study, which reviewed dozens of studies involving over 9,000 of patients, compared the effects of GLP-1 agonists with other pills.
The team point out that people who lose weight through lifestyle changes alone usually have a less rapid creep back—perhaps 0.1 kg a month—once they finish.
The Reason for the Fast Rebound
Doctors propose the mode of action of the jabs accounts for the accelerated weight return.
The injections imitate a natural hormone called GLP-1, which controls feelings of fullness.
"Sustained high doses of the hormone concentrations far above than normal may cause the body to generate a reduced amount of its own natural GLP-1, and could diminish sensitivity to its effects," noted Dr. Adam Collins, a nutrition researcher.
"Discontinuation of this medication leads to appetite is unsuppressed, making binge eating far more likely."
An Ongoing Disease?
Health authorities suggest the injections for people with weight-linked medical conditions, accompanied by prescribed lifestyle changes.
Professionals argue that, considering the significant potential of weight regain, the therapy should be considered ongoing.
This perspective is supported by pharmaceutical companies, who say that the findings "highlight the long-term nature of excess weight," comparing it to managing conditions like diabetes.
User Experiences
Individuals who have come off the medication describe a sudden resurgence of appetite.
"It felt as if a trigger activating and you're instantly starving," recalled an individual.
This difficulty is exacerbated if individuals have not established sustainable lifestyle or habit changes during therapy.
Growing Interest
Recent estimates indicate that a significant number of people in the UK have tried weight-loss jabs in the last 12 months, with interest remaining high.
- Adoption is more common among women compared to men.
- The 40s and 50s demographic shows the greatest usage rates.
- Many obtain the medications through private prescriptions rather than public health services.
In conclusion, experts caution that while the jabs are powerful agents for weight loss, they are not a magic fix and long-term success hinges on combined lifestyle support.